(Q83408863)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

main subject

phase II clinical trial

1 reference

1 reference

L Vormittag

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

C Lemaire

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

D Radonjic

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

G Kornek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

E Selzer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

10 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

Strahlentherapie und Onkologie

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

235-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318328%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00066-011-0040-9

22 January 2020

exact match

0 references

cites work

A review on re-irradiation for recurrent and second primary head and neck cancer

1 reference

12 December 2020

How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?

1 reference

12 December 2020

Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement

1 reference

12 December 2020

Reirradiation of recurrent head and neck cancers with curative intent

1 reference

12 December 2020

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

1 reference

12 December 2020

Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study

1 reference

12 December 2020

Chemotherapy in head and neck cancer

1 reference

12 December 2020

Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?

1 reference

12 December 2020

Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial

1 reference

12 December 2020

Docetaxel: an active drug for squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma

1 reference

12 December 2020

Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911

1 reference

12 December 2020

LENT SOMA scales for all anatomic sites

1 reference

12 December 2020

Chemo-reirradiation in persistent/recurrent head and neck cancers

1 reference

12 December 2020

Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy

1 reference

12 December 2020

Clinical experience with retreatment for palliation

1 reference

12 December 2020

Combined-modality therapy for rectal cancer: future prospects

1 reference

12 December 2020

The radiation dose-response of the human spinal cord.

1 reference

12 December 2020

Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx

1 reference

12 December 2020

Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer

1 reference

12 December 2020

Proposal of human spinal cord reirradiation dose based on collection of data from 40 patients

1 reference

12 December 2020

A phase II trial of paclitaxel in squamous cell carcinoma of the head and neck with correlative laboratory studies

1 reference

12 December 2020

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

12 December 2020

Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390)

1 reference

12 December 2020

Reirradiation in squamous cell head and neck cancer: recent developments and future directions

1 reference

12 December 2020

Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer

1 reference

12 December 2020

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

1 reference

12 December 2020

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma

1 reference

12 December 2020

Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease

1 reference

12 December 2020

X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts

1 reference

12 December 2020

Extent and kinetics of recovery of occult spinal cord injury

1 reference

12 December 2020

Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer

1 reference

12 December 2020

Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy

1 reference

12 December 2020

Re-irradiation in the management of isolated neck recurrences: current status and recommendations

1 reference

12 December 2020

Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol

1 reference

12 December 2020

Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review

1 reference

12 December 2020

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

1 reference

12 December 2020

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

12 December 2020

IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer

1 reference

12 December 2020

Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer

1 reference

12 December 2020

Preoperative Oxaliplatin, Capecitabine, and External Beam Radiotherapy in Patients with Newly Diagnosed, Primary Operable, cT3NxM0, Low Rectal Cancer

1 reference

12 December 2020

Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Platinum-based chemotherapy plus cetuximab in head and neck cancer

1 reference

12 December 2020

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

1 reference

12 December 2020

Re-irradiation of the human spinal cord.

1 reference

12 December 2020

Outcome after re-irradiation of head and neck cancer patients.

1 reference

12 December 2020

Retreatment of the spinal cord with palliative radiotherapy

1 reference

12 December 2020

Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?

1 reference

12 December 2020

Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study

1 reference

12 December 2020